15 Aug 2019late filing notice▼ Bad
GB SCIENCES INC notified the SEC that its quarterly report would be filed late.
Announcements, explained
Each one in plain English, with the numbers worked through for a shareholder.
2 July 2019agm notice● Neutral
GB SCIENCES INC shareholders approved the routine matters put to a vote at the company's annual meeting (director elections, auditor ratification, and the executive-pay advisory vote).
1 July 2019late filing notice▼ Bad
GB SCIENCES INC notified the SEC that its annual report would be filed late.
21 June 2019security holder rights change● Neutral
From June 17, 2019 the company let holders exercise its outstanding warrants at a reduced $0.10 per share, until July 11, 2019. This is another warrant repricing, continuing the earlier ones, and more shares would result if exercised.
7 June 2019agm notice● Neutral
GB SCIENCES INC shareholders approved the routine matters put to a vote at the company's annual meeting (director elections, auditor ratification, and the executive-pay advisory vote).
10 May 2019securities registration● Neutral
GB SCIENCES INC amended a filing by which it registered a securities offering with the SEC.
3 May 2019securities registration● Neutral
GB SCIENCES INC registered a securities offering with the SEC.
17 Apr 2019securities registration● Neutral
GB SCIENCES INC amended a filing by which it registered a securities offering with the SEC.
12 Mar 2019securities registration● Neutral
GB SCIENCES INC amended a filing by which it registered a securities offering with the SEC.
12 Mar 2019securities registration● Neutral
GB SCIENCES INC registered a securities offering with the SEC.
27 Feb 2019securities registration● Neutral
GB SCIENCES INC amended a filing by which it registered a securities offering with the SEC.
19 Feb 2019quarterly activities report▼ Bad
GB SCIENCES INC reported quarterly revenue of $696 thousand and a net loss of $3.8 million for the period ended 2018-12-31.
14 Feb 2019late filing notice▼ Bad
GB SCIENCES INC notified the SEC that its quarterly report would be filed late.
18 Dec 2018securities registration● Neutral
GB SCIENCES INC amended a filing by which it registered a securities offering with the SEC.
21 Nov 2018securities registration● Neutral
GB SCIENCES INC amended a filing by which it registered a securities offering with the SEC.
16 Nov 2018quarterly activities report▼ Bad
GB SCIENCES INC reported quarterly revenue of $717 thousand and a net loss of $9.7 million for the period ended 2018-09-30.
14 Nov 2018quarterly activities report▼ Bad
GB SCIENCES INC reported quarterly revenue of $717 thousand and a net loss of $9.7 million for the period ended 2018-09-30.
2 Nov 2018agm notice● Neutral
GB SCIENCES INC shareholders approved the routine matters put to a vote at the company's annual meeting (director elections, auditor ratification, and the executive-pay advisory vote).
24 Oct 2018securities registration● Neutral
GB SCIENCES INC filed notice of an exempt private placement.
22 Oct 2018agm notice● Neutral
GB SCIENCES INC shareholders approved the routine matters put to a vote at the company's annual meeting (director elections, auditor ratification, and the executive-pay advisory vote).
24 Sept 2018capital raising announcement● NeutralMajor
The company issued 16,482,000 shares to fourteen buyers for $4,120,500 (about $0.25 a share, which is arithmetic from the filing's figures). The filing gives no purpose for the money, and the issue dilutes existing holders.
20 Sept 2018securities registration● Neutral
GB SCIENCES INC registered a securities offering with the SEC.
14 Aug 2018quarterly activities report▼ Bad
GB SCIENCES INC reported quarterly revenue of $1.3 million and a net loss of $5.2 million for the period ended 2018-06-30.
27 July 2018director interest notice● Neutral
John C Poss became a GB SCIENCES INC Chief Executive Officer and company insider (initial ownership filing).
27 July 2018director interest notice● Neutral
GB SCIENCES INC Chief Executive Officer John C Poss bought 99,964 shares on the open market.
28 Feb 2018material agreement termination● NeutralMajor
On February 23, 2018 the company ended all agreements with Pacific Leaf, the lender and technology licensor since 2015. It paid $1,269,818.05 at signing and owes a further $1,500,000 and 1,600,000 restricted shares by July 31, 2018; no relationship remains afterwards. This should end the convertible note and royalty obligations, though the filing does not say how much note debt was outstanding.
14 Feb 2018quarterly activities report▼ Bad
GB SCIENCES INC reported quarterly revenue of $1.3 million and a net loss of $7.0 million for the period ended 2017-12-31.
12 Jan 2018agm notice● Neutral
GB SCIENCES INC shareholders approved the routine matters put to a vote at the company's annual meeting (director elections, auditor ratification, and the executive-pay advisory vote).
22 Dec 2017agm notice● Neutral
GB SCIENCES INC shareholders approved the routine matters put to a vote at the company's annual meeting (director elections, auditor ratification, and the executive-pay advisory vote).
22 Dec 2017substantial holder notice● Neutral
Lawrence B. Ordower reported a GB SCIENCES INC shareholding of 17,564,300 shares (13.70% of votes) in a periodic institutional filing.